Clinical Trial Update: A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed in Bangladesh evaluated how different treatment regimens for visceral leishmaniasis, along with host immunological, genetic, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-kala-azar Dermal Leishmaniasis
• Visceral Leishmaniasis

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Post-kala-azar Dermal Leishmaniasis | Phase 4 | Status: COMPLETED